Parker Waichman LLP Headlines by Topic
Anaphylactic Shock
FDA Requests Label Change for All Sleep Disorder Drug Products
Mar 14, 2007
| www.fda.gov
The U.S. Food and Drug Administration (FDA) has requested that all manufacturers of sedative-hypnotic drug products, a class of drugs used to induce...
Xolair Linked to Risk for Delayed-Onset Anaphylaxis
Feb 22, 2007
| www.medscape.com
Omalizumab subcutaneous injection (Xolair, made by Genentech, Inc) may be linked to life-threatening anaphylaxis, according to a warning from the US...
FDA Issues New Warning About Asthma Drug Xolair
Feb 22, 2007
| NewsInferno.com
Citing reports of severe, potentially fatal allergic reactions, the U.S. Food and Drug Administration (FDA) has issued a new warning about...
FDA orders stronger asthma drug warning
Feb 21, 2007
| AP
The government ordered stronger label warnings for an injected asthma medication Wednesday because of reports some patients taking the drug, marketed...
FDA Proposes to Strengthen Label Warning for Xolair
Feb 21, 2007
| www.fda.gov
The Food and Drug Administration (FDA) announced that it has requested Genentech, Inc. add a boxed warning to the product label for omalizumab,...
FDA orders warnings for Xolair
Feb 21, 2007
| UPI
The U.S. Food and Drug Administration ordered Genentech Inc. to add a boxed warning to its asthmatic drug marketed as Xolair. The FDA said the boxed...
Page 1/1
